Drugs Warnings for ADHD
Drugs Warnings for ADHD
FDA Panel Recommends Warnings of Rare Reports of Aggressive Behavior or Psychotic Symptoms
Matthew Cabrey, a spokesman for Adderall manufacturer Shire Pharmaceuticals, said that the company "agrees with and is supportive" of calls to highlight adverse events that can occur with use of the drug.
The FDA has not yet issued a decision on last month's call to add black box heart warnings for adults.
"We have some work to do in adults," said Robert Temple, MD, the FDA's director of medical policy.
New Warnings Urged for ADHD Drugs
FDA Panel Recommends Warnings of Rare Reports of Aggressive Behavior or Psychotic Symptoms
Cardiovascular Risks continued...
Matthew Cabrey, a spokesman for Adderall manufacturer Shire Pharmaceuticals, said that the company "agrees with and is supportive" of calls to highlight adverse events that can occur with use of the drug.
The FDA has not yet issued a decision on last month's call to add black box heart warnings for adults.
"We have some work to do in adults," said Robert Temple, MD, the FDA's director of medical policy.
Source...